Alnylam Pharmaceuticals (ALNY) Options Chain & Prices $459.66 +2.71 (+0.59%) Closing price 10/10/2025 03:59 PM EasternExtended Trading$445.52 -14.14 (-3.08%) As of 10/10/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALNY Put and Call Options List 1/15/2027 7/17/2026 6/18/2026 3/20/2026 1/16/2026 12/19/2025 11/21/2025 10/17/2025 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export to Excel ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades10/17/2025$390.00$0.226Put66 - 9(+0)56.63% (-3.30%)-0.017553510/17/2025$400.00$0.399Put13310479(+1)53.73% (-2.32%)-0.030229210/17/2025$410.00$0.711Put8 - 8287(+0)50.98% (-1.32%)-0.051959110/17/2025$420.00$1.272Put3 - - 537(+0)48.44% (-0.31%)-0.088456210/17/2025$430.00$2.272Put3 - 2194(+0)46.17% (+0.69%)-0.147369210/17/2025$450.00$6.833Put2 - - 197(+0)42.81% (+2.32%)-0.357744110/17/2025$450.00$15.902Call2 - - 28(+0)42.81% (+2.32%)0.642189110/17/2025$460.00$10.195Call31 - 42(-12)41.90% (+2.67%)0.497966210/17/2025$470.00$6.101Call312448(+0)41.60% (+2.56%)0.353449210/17/2025$480.00$24.383Put1 - 15(+0)41.86% (+2.07%)-0.7676981 Get the Latest News and Ratings for ALNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/17/2025$480.00$3.461Call11 - 134(+11)41.86% (+2.07%)0.231513110/17/2025$490.00$32.817Put1 - 13(+0)42.59% (+1.36%)-0.856269110/17/2025$500.00$1.035Call431300(+0)43.67% (+0.64%)0.0850224End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Amgen Options Data Gilead Sciences Options Data Vertex Pharmaceuticals Options Data Regeneron Pharmaceuticals Options Data Biogen Options Data United Therapeutics Options Data Incyte Options Data Neurocrine Biosciences Options Data Ionis Pharmaceuticals Options Data Exact Sciences Options Data Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NASDAQ:ALNY) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
